• 6.7.2017 עדכוני חקיקה ופסיקה דיני עבודה יולי 2017

    עדכוני חקיקה ופסיקה בדיני עבודה - יולי 2017  לחץ/י כאן למזכר

  • 15.5.2017 Sweet Inn raises $22M

    Daniel Chinn and Hila Faber of our firm represented Qumra Capital (Qumra) in its investment as part of a $22 million funding round led by Qumra, with additional investment from BRM Group and other European investors, in Israeli resort suite booking company Sweet Inn. See press release.

  • 3.5.2017 Loom Systems Raises $6 million

    Uri Nesher and Mati Rosenbaum of our firm represented Jerusalem Venture Partners (JVP) in its investment as part of a $6 million funding round led by JVP, with additional investment from Meron Capital and 31Ventures Global Innovation Fund, in Loom Systems Ltd., an Israeli AI-powered log analysis software platform developer. See press release. 

  • 5.4.2017 ®RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam

    Gershon Shalom-Winter of our firm represented RedHill BioPharma Ltd. (NASDAQ/TASE: RDHL)  in connection with the acquisition from Entera Health Inc. of exclusive rights in the U.S. to EnteraGam®, a commercially-available medical food, comprising a serum-derived bovine immunoglobulin/protein isolate (SBI), which must be administered under medical supervision.  RedHill BioPharma is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal (GI) and inflammatory diseases and cancer.  See Press Release.

  • 6.3.2017 Advanced Vision Technology Ltd. acquired by Danaher Corp for $100M

    David Cohen, Uri Barak and Lior Etgar of our firm represented Israeli automatic print inspection systems company - Advanced Vision Technology Ltd. (XETRAL VSJ) in its acquisition by US technology company Danaher Corp for $100 million. AVT is the only Israeli company listed for trade on the Frankfurt Stock Exchange.  See press release.

  • 1.2.2017 השכרת מבנה אופק 11 בפארק העסקים של קיסריה לחממה הטכנולוגית OpenValley

    עו"ד גליה זיסקינד ומעין מילא ממשרדנו ייצגו את החברה לנכסי קיסריה, במו"מ על השכרת כל מבנה אופק 11 שפארק העסקים של קיסריה, לחממה הטכנולוגית OpenValley.

  • 3.1.2017 RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement with Concordia for GI Drug Donnatal®

     Gershon Shalom-Winter of our firm represented RedHill BioPharma (NASDAQ/TASE: RDHL)  in connection with an exclusive co-promotion agreement with a subsidiary of Concordia International Corp. (NASDAQ: CXRX) (TSX: CXR), an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, granting RedHill certain U.S. promotion rights for Donnatal.  See Press Release.

  • 3.1.2017 CONTIPI MEDICAL LTD RAISES APPROXIMATELY $2 MILLION IN SERIES A FINANCING ROUND

    Gershon Shalom-Winter of our firm represented ConTIPI Medical Ltd., an Israeli developer of non-invasive, disposable solutions for pelvic floor dysfunction in women, in its Series A Preferred Share investment round in which it has raised almost $2,000,000.

  • 14.12.2016 RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. in South Korea

    Gershon Shalom-Winter of our firm represented RedHill BioPharma (NASDAQ/TASE: RDHL)  in connection with an exclusive license agreement with Pharmatronic Co. for the commercialization in South Korea of RIZAPORT®.  RIZAPORT®. is a proprietary oral thin film formulation of rizatriptan for the treatment of acute migraines. See Press Release.

  • 14.9.2016 נדחתה עתירת תושבי קיסריה שהשכירו את בתיהם למסיבות

     

    עורכי הדין מנחם (טולי) טולצ'ינסקי ואלעד מירוויס ייצגו את החברה לפיתוח קיסריה בתביעה אשר הוגשה נגדה לבית המשפט המחוזי בתל-אביב, על ידי מספר בעלי נכסים ביישוב קיסריה (ת.א. 46419-11-13). במוקד התביעה עמדו טענות שונות של אותם תובעים כנגד פעילותה של החברה לפיתוח קיסריה ביישוב, והמערכת ההסכמית שנחתמת בינה לבין כל מי שמבקש לרכוש נכס ביישוב. ביום 14.9.2016 ניתן פסק הדין של בית המשפט המחוזי במסגרתו דחה בית המשפט באופן מלא את טענות התובעים כנגד מהות פעילותה של החברה לפיתוח קיסריה וההסדרים הכלולים בהסכמים שנחתמים בינה לבין בעלי נכסים ביישוב, תוך שהוא מקבל את טענות החברה לפיתוח קיסריה בעניינים אלו, ומחייב את התובעים בתשלום הוצאות משפט ושכר טרחה בסך כולל של 80,000 ש"ח. לקריאת כתבה בנושא לחצו כאן

  • 5.7.2016 RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT for Migraines with Grupo JUSTE in Spain and Additional Potential Territories

    Gershon Shalom-Winter of our firm represented RedHill BioPharma in connection with an exclusive license agreement with Grupo JUSTE for the commercialization of RIZAPORT™ in Spain, and a right of first refusal for additional territories. RIZAPORT is a proprietary oral thin film formulation of rizatriptan for the treatment of acute migraine  See press release.

  • 5.7.2016 Israeli automated drone system Airobotics raises $28.5 million, including from Charles Rivers Ventures

    Gershon Shalom-Winter and Efrat Shuster of our firm represented Charles River Ventures in connection with its S12,000,000 lead investment in Airobotics Ltd. Airobotics is developing an unmanned drone for use by complex businesses. See Article.

  • 29.6.2016 עתירה לביטול סעיפים בחוק הסופרים

    יזם ההי טק והסופר מייקל אייזנברג יחד עם קבוצות סופרים ומוציאים לאור עתרו אתמול (28.6.16) לבג"ץ באמצעות עוה"ד אסף בנמלך, נעמה הורן ומתי רוזנבאום ממשרדנו, לביטול סעיפי החוק הקובעים כי המגבלות שמטיל חוק הספרים על מכירתם של ספרים חדשים ימשיכו לחול, אף לאחר ביטולו, על ספרים שראו אור או שיראו אור עד ליום 31.8.16

     .לקריאת ההודעה לעיתונות לחצו כאן 

     .לקריאת העתק כתב העתירה לחצו כאן

  • 22.6.2016 מזכר - הגדלת שעורי הפרשות לביטוח פנסיוני; עדכון מכסת ימי חופשה שנתית; ועדכון שכר מינימום

    להלן מזכר בנושא הגדלת שעורי הפרשות לביטוח פנסיוני, עדכון מכסת ימי חופשה שנתית, ועדכון שכר מינימום  לחץ/י כאן למזכר

  • 10.2.2016 RISKIFIED RAISES $25MILLION IN FINANCING ROUND

    Daniel Chinn, Aaron Shaw and Mati Rosenbaum of our firm represented Qumra Capital and The Phoenix Insurance Company Ltd. in their investment as part of a $25 million funding round led by Qumra Capital, with additional investments from other investors, in Riskified Ltd., an Israeli e-commerce fraud prevention developerSee press release.

  • 9.12.2015 Teva Pharmaceutical Industries - Closing of Two Concurrent Public Offerings Totaling $6.75 billion

    Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that it has closed two concurrent equity offerings totaling $6.75 billion, consisting of 54 million American Depositary Shares and 3,375,000 of its 7.00% Mandatory Convertible Preferred Shares. A team from our firm led by partners Menachem Tulchinsky, David Cohen, Isaac Maricano, Asaf Ben-Zeev and Dafna Achiam-Tal and associates Elad Mirvis, Lior Etgar and Ofer Ben-Dayan, advised Teva in the offerings. See press release.

  • 8.12.2015 Lemonade Inc. raises $13 Million in Seed Financing

     Daniel Chinn and Yair Eliash of our firm represented Lemonade Inc.,a soon to launch peer-to-peer (P2P) insurance company, in its recent $13 million seed financing round led by Aleph and Sequoia Capital. See press release. 

  • 26.11.2015 Iguaz.io Raises $15 Million in Series A Financing Round

    Daniel Chinn and Uri Nesher of our firm represented Jerusalem Venture Partners (JVP) in its investment as part of a $15 million Series A funding round led by Magma Venture Partners, with additional investments from large strategic investors, in Iguaz.io, a provider of innovative data management and storage solutions for Big Data, IoT and cloud applications. See press release.

  • 8.10.2015 SolarPower Ltd. Purchased By Orad Control Systems

    Doron Stern, Uri Nesher and Aaron Shaw of our firm represented SolarPower Ltd. (which designs, builds, and maintains solar power systems, and also initiates alternative energy projects in Israel) and its shareholders in an agreement to acquire all of the shares in SolarPower by Orad Control Systems Ltd., for an amount of approximately NIS 4 millionSee press release.

  • 6.10.2015 Israeli cyber security startup Morphisec raises $7 Million

    Daniel Chinn of our firm represented Jerusalem Venture Partners (JVP) which led a $7 million funding round, together with GE Ventures (NYSE:GE), Deutsche Telekom (XETRA: DTE), Portage Advisors llc. and OurCrowd, in Morphisec, a leading developer of cyber security prevention and detection tools. See press release.

  • 30.9.2015 Teridion Raises $15 Million is Series B financing Round

    Daniel Chinn and Itamar Shoham of our firm represented Jerusalem Venture Partners (JVP) which led a $15 million Series B round of financing, together with Magma Venture Partners and Singtel Innov8, in Teridion, the Israeli cloud-based networking company which delivers a much faster internet experience. See press release.

  • 27.7.2015 Teva Pharmaceutical Industries Ltd. to acquire Allergan Generics for $40.5 billion

    Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a leading global pharmaceutical company, announced that it has signed a definitive agreement with Allergan Plc to acquire Allergan Generics in a transaction valued at $40.5 billion, to be paid in a combination of cash and stock. A team from our firm led by partners Menachem Tulchinsky, David Cohen and Dafna Achiam-Tal and associates Lior Etgar and Ofer Ben-Dayan, advised Teva in the transaction. See press release. 

  • 23.7.2015 Leadspace Ltd. closes new financing round

    Daniel Chinn and Aaron Shaw of our firm represented the investors in the recent financing of Leadspace Ltd., an Israeli corporation which provides an end-to-end predictive analytics platform. See press release. 

  • 14.7.2015 AnyClip Media Completes Financing Round

    AnyClip Media Ltd., a leading content marketing platform for distributing premium branded video, announced today it has completed a funding round of $21M and leading participants included new investors Ervington Investments, representing the interests of Russian businessman Roman Abramovich, and Limelight Networks (LLNW), a global leader in digital content delivery. AnyClip was represented in the transaction by Daniel Chinn and Uri Nesher of Tulchinsky Stern Marciano Cohen Levitski & Co. See press release.

  • 2.6.2015 GameFly Inc. Acquires Playcast Media Systems Ltd.

    GameFly Inc., announced its acquisition of Playcat Media Systems Ltd., the Israel-based cloud gaming platform company. Playcast's Israeli shareholders include JVP, Mer Group and Xenia. The selling shareholders were represented in the transaction by Daniel Chinn of Tulchinsky Stern Marciano Cohen Levitski & Co. See press release.

  • 4.2.2015 על מיסוי אופציות 102

    פוסט קצר שכתבה עו"ד לירון לוי-גבאי, מהמחלקה המסחרית של משרדנו

     לקריאת הפוסט לחצו כאן.

  • 3.2.2015 מזכר - הודעה למועמד לעבודה בדבר הליכי מיון וקבלה לעבודה

       להלן מזכר בנושא הודעה למועמד לעבודה בדבר הליכי מיון וקבלה לעבודה.   לחץ/י כאן למזכר.

  • 3.2.2015 מזכר - העלאת סכומי שכר המינימום

        להלן מזכר בנושא העלאת סכומי שכר המינימום.   לחץ/י כאן למזכר.

  • 7.10.2014 מזכר (דיני עבודה) - צו הרחבה חדש בענף השמירה והאבטחה

      להלן מזכר בנושא צו ההרחבה החדש בענף השמירה והאבטחה.   לחץ/י כאן למזכר.

  • 22.9.2014 HoneyBook Raises $10 Million in Series A Financing

    On September 22nd, 2014, HoneyBook Inc., a maker of business software for wedding planners and related vendors, announced that it secured $10M in a Series A round led by Aleph VC, joined by Hillsven VC, Ooga Labs, and a number of angel investors, among them Twitter and Medium founder Ev Williams, and AngelList CEO Naval Ravikanttwo. Aleph VC was represented in the transaction by advocate Daniel Chinn of Tulchinsky Stern Marciano Cohen Levitski & Co. See press release.

  • 15.7.2014 RedHill Biopharma Acquires Phase II Oncology Drug MESUPRON® from WILEX AG

    Our firm represented RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) in its acquisition of the exclusive development and commercialization rights to MESUPRON®, a promising new non-cytotoxic approach to cancer therapy, from Munich-based WILEX AG (ISIN DE0006614720 / WL6 / FSE). Under the terms of the agreement, RedHill will pay WILEX an upfront payment of USD 1 million and potential tiered royalties on net revenues. See press release.

  • 7.7.2014 ORBOTECH TO ACQUIRE SPTS TECHNOLOGIES TO EXTEND LEADERSHIP IN ADVANCED MICRO MANUFACTURING

    Orbotech Ltd. (NASDAQ: ORBK) announced the signing of a definitive share purchase agreement to acquire SPTS Technologies Group Limited, a U.K.-based leading manufacturer of etch, deposition and thermal processing equipment for the microelectronics industry, from European private equity firm Bridgepoint and others.  The combined companies’ comprehensive offering is expected to enable the leading designers of consumer electronics to turn their vision of next generation devices into reality. Under the terms of the agreement, Orbotech will acquire SPTS for a total consideration (including repayment or assumption of debt) of approximately $370 million in cash. 
    Orbotech was represented in the transaction by partners David Cohen and Asaf Ben-Zeev. See press release.

  • 21.5.2014 Clarizen closes a $35 million venture funding round

    Clarizen, the leader in enterprise work collaboration software, has closed a $35 million venture funding round led by Goldman Sachs & Co. This latest Series F investment round brings Clarizen’s total funding to date to $90 million. All existing investors, including Benchmark Capital, Carmel Ventures, Opus Capital and, Vintage Investment Partners who were represented by Daniel Chinn of Tulchinsky Stern Marciano Cohen Levitski & Co. also participated in the round. See press release.

  • 9.4.2014 JVP LEADS $7 MILLION ROUND IN GREENSQL

    GreenSQL, a leader in unified database security and compliance, announced today that Jerusalem Venture Partners (JVP), Israel’s leading venture firm in the cyber-security sector, would be investing in the company with participation from all its existing investors including Magma Venture Capital, Rhodium, Atlantic Capital Partners, Gandyr and 2Bangels. JVP’s investment in GreenSQL reinforces its emphasis on identifying leading Israeli cyber-security firms with strong technological advantages and immense growth potential. JVP is the lead investor in several of Israel’s top cyber-security companies including CyberArk, Nativeflow, ThetaRay, CyActive and operates the JVP Cyber Labs incubator in Beer Sheva. JVP was represented in the transaction by advocates Daniel Chinn and Uri Nesher of Tulchinsky Stern Marciano Cohen Levitski & Co. See press release.

  • 18.3.2014 Galmed Pharmaceuticals Announces Closing of Initial Public Offering

    Galmed Pharmaceuticals Ltd. (Nasdaq:GLMD) announced the closing of its initial public offering. The aggregate gross proceeds from the sale of its shares in the offering were approximately $44.1 million, before deducting underwriting discounts, commissions and other estimated offering expenses. The ordinary shares issued in the offering are listed on NASDAQ Capital Market under the trading symbol “GLMD.” Galmed was advised by partners Uri Barak and Daniel Chinn and associates Lana Tavor, Liron Levi Gabay and Lior Etgar. See press release.

  • 11.3.2014 From "Jump Start Nation" to "Start Up Nation"

    Adv. Doron Stern's article, From "Jump Start Nation" to "Start Up Nation", was featured in the Best Lawyers website. See article.

  • 11.3.2014 RedHill Biopharma Provides Update on RHB-102 Development and Intellectual Property

    Our firm represented RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) in its license from Temple University of patents related to RHB-102, a once daily oral formulation of the anti-emetic drug ondanestron. The firm's team was led by Gershon Shalom-Winter and Lana Tavor. See press release

  • 5.3.2014 COMPUGEN LTD. CLOSES FOLLOW-ON UNDERWRITTEN PUBLIC OFFERING

    Our firm served as Israeli counsel to Compugen Ltd. (NASDAQ: CGEN; TASE: CGEN), a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies to address important needs in the fields of immunology and oncology, in its follow-on underwritten public offering of 6,900,000 ordinary shares, including 900,000 shares sold pursuant to the full exercise of an option granted to the underwriters to purchase additional shares, at a price to the public of $10.50 per share. Gross proceeds to Compugen were approximately $72.5 million. Our firm's team was led by David Cohen and Dafna Achiam Tal. See press release. 

  • 27.2.2014 RedHill and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement

    RedHill Biopharma (NASDAQ: RDHL; TASE: RDHL) and Salix Pharmaceutical's (NASDAQ: SLXP) announced today that the companies have entered into an exclusive agreement by which Salix has licensed the worldwide exclusive rights to RedHill's RHB-106 encapsulated formulation for bowel preparation and rights to other purgative developments. Financial terms of the transaction include an upfront payment of $7 million and $5 million in subsequent milestone payments to RedHill. Salix also has agreed to pay RedHill tiered royalties on net sales, ranging from low single-digit up to low double-digits. Under the worldwide license agreement, the parties also agreed on potential strategic collaboration with regard to certain other Salix products in specific territories.
    Redhill was represented by Advocates Gershon (Glenn) Shalom-Winter and Lana Tavor of Tulchinsky Stern Marciano Cohen Levitski & Co. 
    See press release. 

  • 25.2.2014 מזכר - החוק להגברת אכיפת דיני העבודה

    להלן מזכר בנושא החוק להגברת אכיפת דיני עבודה ותיקון מספר 8 לחוק העסקת עובדים על ידי קבלני כוח אדם.  לחץ/י כאן למזכר.

  • 25.2.2014 מזכר (דיני עבודה)- שימושי מחשב במקום העבודה

     להלן מזכר בנושא שימושי מחשב במקום העבודה - צפיית מעסיק בתכתובת דוא"ל של עובדלחץ/י כאן למזכר.

     
     
  • 19.2.2014 White Mountains Investments Acquires 60.5% of Wobi Insurance agency ltd

    Following approval by the Israeli Insurance Commissioner, White Mountains Investments (Luxembourg) S.á r.l. , a company directly controlled by White Mountains Insurance Group, Ltd., a financial services company publicly traded on the New York Stock Exchange and the Bermuda Stock Exchange, has acquired approximately 60.5% of the shares of Wobi Insurance Agency Ltd., an insurance comparison website, by way of purchase of shares from current shareholders (for an aggregate consideration of approximately NIS 14,000,000) and investment in Wobi (together with Rubicon Business Group Ltd., a current shareholder) of NIS 18,000,000 in consideration for Preferred A Shares. White Mountains was represented in the transaction by advocates David Cohen, Asaf Ben-Zeev and Avital Mandel of Tulchinsky Stern Marciano Cohen Levitski & Co See press release.

  • 9.2.2014 מזכר (דיני עבודה) - צו ההרחבה בחדש בענף הניקיון

     להלן מזכר בנושא צו ההרחבה החדש בענף הניקיון.   לחץ/י כאן למזכר.

  • 7.2.2014 Galmed Pharmaceuticals files for NASDAQ IPO

    Galmed Pharmaceuticals, a clinical-stage biotech company developing therapies for liver diseases and gallstones, was advised by Tulchinsky Stern Marciano Cohen Levitski & Co. on its filing with the SEC of a prospectus for the raising of up to $34.5 million in an initial public offering on NASDAQ.  The Tulchinsky Stern Marciano Cohen Levitski & Co. team was led by partners Uri Barak and Daniel Chinn, with support from associates Lana Tavor, Liron Levi Gabay and Lior Etgar. See press release. 

  • 6.2.2014 CyActive joins JVP Cyber Labs incubator in Be'er Sheba

    CyActive recently joined JVP Cyber Labs' cyber incubator in Be'er Sheba. JVP Cyber Labs was represented in the transaction by advocates Daniel Chinn and Uri Nesher of Tulchinsky Stern Marciano Cohen Levitksi & Co. See article.

  • 5.2.2014 Totango raises $15.5 Million

    Totango, a leader in customer success and user engagement management, announced $15.5 million in Series B financing led by new investors from the Canvas Venture Fund and InterWest Partners, with participation from returning investors Pitango Venture Capital and Gemini Israel Ventures. Advocates Doron Stern, Talya Michaelson, Uri Nesher and Itamar Shahar of Tulchinsky Stern Marciano Cohen Levitski & Co. served as Israeli counsel to Canvas Venture Fund and InterWest Partners in the transaction. See press release.

  • 3.7.2013 Aleph Raises $140 Million Fund

    On July 3, 2013, Michael Eisenberg and Eden Shochat announced the successful closing of Aleph, a new $140 million venture capital fund focused on serving Israeli entrepreneurs who want to build big, scaleable global businesses.See press release. 

  • 17.4.2013 Reduxio Systems Raises $9 Million

    On April 17, 2013, Reduxio Systems, a next generation hybrid innovator, announced that it secured $9M in a Series A round led by two of Israel's leading venture capitalist firms, JVP and Carmel Ventures. JVP was represented in the transaction by advocates Daniel Chinn and Uri Nesher of Tulchinsky Stern Marciano Cohen Levitski & Co. See press release.